share_log

Psychedelic Stock Gainers And Losers From January 13, 2023

Psychedelic Stock Gainers And Losers From January 13, 2023

自 2023 年 1 月 13 日起 Psychedelic 股票的涨跌幅
Benzinga Real-time News ·  2023/01/13 16:32

GAINERS:

赢家:

  • GH Research (NASDAQ:GHRS) shares closed up 6.43% at $9.60
  • Mind Medicine (NASDAQ:MNMD) shares closed up 5.14% at $3.27
  • Seelos Therapeutics (NASDAQ:SEEL) shares closed up 4.00% at $0.91
  • Compass Pathways (NASDAQ:CMPS) shares closed up 3.24% at $9.55
  • 生长激素研究 纳斯达克股票代码:GHRS)股价收盘上涨6.43%,至9.60美元
  • 心灵医学 纳斯达克股票代码:MNMD)股价收盘上涨5.14%,至3.27美元
  • Seelos Therap 纳斯达克股票代码:SEEL)股价收盘上涨4.00%,至0.91美元
  • 罗盘之路 纳斯达克股票代码:CMPS)股价收盘上涨3.24%,至9.55美元

LOSERS:

失败者:

  • Cybin (AMEX:CYBN) shares closed down 5.23% at $0.44
  • ATAI Life Sciences (NASDAQ:ATAI) shares closed down 1.64% at $1.80
  • Numinus Wellness (OTC:NUMIF) shares closed down 1.42% at $0.17
  • Intelgenx Technologies (OTC:IGXT) shares closed down 0.84% at $0.24
  • Cybin (AMEX: CYBN)股价收盘下跌5.23%,至0.44美元
  • ATAI 生命科学 纳斯达克股票代码:ATAI)股价收盘下跌1.64%,至1.80美元
  • 努米努斯健康 (场外交易代码:NUMIF)股价收盘下跌1.42%,至0.17美元
  • 英特尔根克斯科技 (场外交易代码:IGXT)股价收盘下跌0.84%,至0.24美元

This article was generated by Benzinga's automated content engine and reviewed by an editor.

本文由Benzinga的自动内容引擎生成,并由编辑审阅。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发